IRIS Accounts Production v25.1.4.42 11718231 Board of Directors 1.1.24 31.12.24 31.12.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh117182312023-12-31117182312024-12-31117182312024-01-012024-12-31117182312022-12-31117182312023-01-012023-12-31117182312023-12-3111718231ns15:EnglandWales2024-01-012024-12-3111718231ns14:PoundSterling2024-01-012024-12-3111718231ns10:Director12024-01-012024-12-3111718231ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3111718231ns10:SmallEntities2024-01-012024-12-3111718231ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3111718231ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3111718231ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3111718231ns10:FullAccounts2024-01-012024-12-311171823112024-01-012024-12-3111718231ns10:Director22024-01-012024-12-3111718231ns10:RegisteredOffice2024-01-012024-12-3111718231ns5:CurrentFinancialInstruments2024-12-3111718231ns5:CurrentFinancialInstruments2023-12-3111718231ns5:ShareCapital2024-12-3111718231ns5:ShareCapital2023-12-3111718231ns5:RetainedEarningsAccumulatedLosses2024-12-3111718231ns5:RetainedEarningsAccumulatedLosses2023-12-3111718231ns5:NetGoodwill2024-01-012024-12-3111718231ns5:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3111718231ns5:PlantMachinery2024-01-012024-12-3111718231ns5:ComputerEquipment2024-01-012024-12-3111718231ns5:NetGoodwill2023-12-3111718231ns5:NetGoodwill2024-12-3111718231ns5:NetGoodwill2023-12-3111718231ns5:PlantMachinery2023-12-3111718231ns5:ComputerEquipment2023-12-3111718231ns5:PlantMachinery2024-12-3111718231ns5:ComputerEquipment2024-12-3111718231ns5:PlantMachinery2023-12-3111718231ns5:ComputerEquipment2023-12-3111718231ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3111718231ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-31
REGISTERED NUMBER: 11718231 (England and Wales)












UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31ST DECEMBER 2024

FOR

VIROSA NURSERY LIMITED

VIROSA NURSERY LIMITED (REGISTERED NUMBER: 11718231)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


VIROSA NURSERY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST DECEMBER 2024







DIRECTORS: S Vasile
Mrs H R Vasile





REGISTERED OFFICE: Manufactory House
Bell Lane
Hertford
Hertfordshire
SG14 1BP





REGISTERED NUMBER: 11718231 (England and Wales)





ACCOUNTANTS: Cook & Partners Limited
Manufactory House
Bell Lane
Hertford
Hertfordshire
SG14 1BP

VIROSA NURSERY LIMITED (REGISTERED NUMBER: 11718231)

BALANCE SHEET
31ST DECEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 90,000 112,500
Tangible assets 5 588,904 592,731
678,904 705,231

CURRENT ASSETS
Stocks 5,000 5,000
Debtors 6 16,577 58,250
Cash at bank 263,770 105,834
285,347 169,084
CREDITORS
Amounts falling due within one year 7 700,395 646,489
NET CURRENT LIABILITIES (415,048 ) (477,405 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

263,856

227,826

CAPITAL AND RESERVES
Called up share capital 101 101
Retained earnings 263,755 227,725
SHAREHOLDERS' FUNDS 263,856 227,826

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

VIROSA NURSERY LIMITED (REGISTERED NUMBER: 11718231)

BALANCE SHEET - continued
31ST DECEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28th May 2025 and were signed on its behalf by:





S Vasile - Director


VIROSA NURSERY LIMITED (REGISTERED NUMBER: 11718231)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31ST DECEMBER 2024

1. STATUTORY INFORMATION

Virosa Nursery Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going Concern Justification
The directors have assessed various factors and risks affecting the company and its ability in these difficult economic times to continue to trade as a going concern. The directors have not identified any material uncertainties or risks related to events or conditions that could affect the carrying values of the company's assets and liabilities as at the balance sheet date. Therefore the financial statements for the year ended 31st December 2024 have been prepared using the going concern basis of accounting.

Turnover
Revenue - Described as turnover - is the value of goods (net of VAT) provided to customers during the year, plus the value of work (net of VAT) performed during the year with respect to services.

Revenue is recognised on the sale of goods when the goods are delivered and title has passed. Revenue is recognised on the provision of services once completed.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2019, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 5% on cost
Computer equipment - 20% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


VIROSA NURSERY LIMITED (REGISTERED NUMBER: 11718231)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST DECEMBER 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2023 - 11 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1st January 2024
and 31st December 2024 225,000
AMORTISATION
At 1st January 2024 112,500
Amortisation for year 22,500
At 31st December 2024 135,000
NET BOOK VALUE
At 31st December 2024 90,000
At 31st December 2023 112,500

VIROSA NURSERY LIMITED (REGISTERED NUMBER: 11718231)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31ST DECEMBER 2024

5. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1st January 2024 741,541 1,694 743,235
Additions 34,869 - 34,869
At 31st December 2024 776,410 1,694 778,104
DEPRECIATION
At 1st January 2024 148,976 1,528 150,504
Charge for year 38,530 166 38,696
At 31st December 2024 187,506 1,694 189,200
NET BOOK VALUE
At 31st December 2024 588,904 - 588,904
At 31st December 2023 592,565 166 592,731

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 600 12,000
Other debtors 101 101
VAT 15,876 46,149
16,577 58,250

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 87,910 31,792
Tax 40,298 -
Social security and other taxes 4,818 1,013
Directors' current accounts 561,369 607,684
Accrued expenses 6,000 6,000
700,395 646,489